Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

18.42

-0.49 (-2.59%)

At close: Jul 14, 2026, 4:00 PM EDT

18.56

+0.14 (0.76%)

After-hours: Jul 14, 2026, 6:05 PM EDT

Avalo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	968	336	78	7	48	192
Market Cap Growth	1769.22%	332.09%	966.44%	-84.65%	-75.21%	-3.16%
Enterprise Value	886.59	237.86	-56.74	-0.12	53.77	170
Last Close Price	18.42	18.16	7.43	9.10	1209.60	4896.00
PS Ratio	16411.15	5698.16	176.43	3.79	2.63	35.52
PB Ratio	6.64	4.05	0.58	1.00	-4.35	8.31
P/TBV Ratio	1490.06	3.36	0.46	-	-	20.03
EV/Sales Ratio	15027.00	4031.45	-128.66	-0.06	2.98	31.49
EV/EBITDA Ratio	-	-	0.83	0.00	-	-
EV/EBIT Ratio	-	-	0.83	0.00	-	-
EV/FCF Ratio	-	-	1.16	0.00	-	-
Debt / Equity Ratio	-	0	0	0	-1.78	1.42
Net Debt / Equity Ratio	-1.20	-1.18	-1.01	-1.01	-0.57	-0.94
Net Debt / EBITDA Ratio	1.04	1.36	1.97	0.27	-0.17	0.27
Net Debt / FCF Ratio	1.37	1.91	2.74	0.24	-0.23	0.31
Asset Turnover	-	0.00	0.01	0.07	0.32	0.09
Inventory Turnover	-	-	-	128.40	118.41	72.73
Quick Ratio	7.07	7.60	19.33	1.64	0.68	2.99
Current Ratio	7.66	8.14	19.96	1.82	0.74	3.11
Return on Equity (ROE)	-111.97%	-72.43%	-50.06%	1747.11%	-684.77%	-354.08%
Return on Assets (ROA)	-73.32%	-54.70%	-80.05%	-100.67%	-65.97%	-132.20%
Return on Invested Capital (ROIC)	-	-	-	-491.17%	-595.49%	-2350.31%
Return on Capital Employed (ROCE)	-82.54%	-58.98%	-85.56%	-198.00%	-104.61%	-184.87%
Buyback Yield / Dilution	-131.03%	-78.82%	-2599.19%	0.00%	-686.02%	-39.42%
Total Shareholder Return	-131.03%	-78.82%	-2599.19%	0.00%	-686.02%	-39.42%

SEC Filings: 10-K · 10-Q